Trials / Completed
CompletedNCT06525454
Individualized Automatic Target Coaching Message for Glycemic Management and Depressive Symptom
Feasibility and Acceptability of Individualized Automatic Target Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, randomized, prospective, feasibility and acceptability trial in patients with type 1 diabetes. For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires. The control group will remain on their current treatment and will not receive any intervention. The purpose of this trial is to evaluate the feasibility and acceptability of the clinical application of automated, personalized coaching messages for glycemic management and depressive symptom in people with type 1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Personalized coaching messages for blood glucose and emotions | For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires. |
Timeline
- Start date
- 2024-08-07
- Primary completion
- 2024-09-18
- Completion
- 2024-09-30
- First posted
- 2024-07-29
- Last updated
- 2024-11-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06525454. Inclusion in this directory is not an endorsement.